Minerals and vitamins and the risk of bladder cancer: results from the New Hampshire Study by Brinkman, Maree T. et al.
ORIGINAL PAPER
Minerals and vitamins and the risk of bladder cancer:
results from the New Hampshire Study
Maree T. Brinkman • Margaret R. Karagas •
Michael Scott Zens • Alan Schned • Raoul C. Reulen •
Maurice P. Zeegers
Received: 1 May 2009/Accepted: 10 December 2009/Published online: 31 December 2009
 The Author(s) 2009. This article is published with open access at Springerlink.com
Abstract
Objective Although the effect of fruit and vegetables on
the risk of bladder cancer has been widely studied, little is
known about their micronutrient components. Our aim was
to investigate associations between minerals and vitamins
and bladder cancer.
Methods A case–control study was conducted in New
Hampshire, USA. Dietary data were collected from 322
cases and 239 controls using a 121-item food frequency
questionnaire. Odds ratios (ORs) and 95% conﬁdence
intervals (CIs) were calculated using logistic regression
adjusting for sex, age, smoking characteristics, and energy
intake.
Results The ORs (95% CI) for highest quartile versus
lowest quartile for total intake of vitamin E was 0.66 (0.36–
1.20; p trend = 0.09) and 0.49 (0.21–1.17; p trend = 0.13)
for dietary phosphorus. The odds of bladder cancer for
heavy smokers with the highest total intake of vitamin E,
carotenoids, and niacin were 0.58 (0.34–0.99), 0.62 (0.36–
1.09), and 0.66 (0.39–1.14), respectively. Higher total
intakes of carotenoids, vitamin D, thiamin, niacin, and
vitamin E were inversely related to bladder cancer risk
among older individuals.
Conclusion Our ﬁndings suggest further investigation of
the effect of vitamin E, carotenoids, vitamin D, thiamin,
and niacin on bladder cancer risk may be warranted. Future
studies should focus on high risk groups such as heavy
smokers and older individuals.
Keywords Bladder cancer  Minerals  Vitamins 
Carotenoids  Folate
Introduction
In 2002, a global study reported that the US had among the
highest reported age standardized incidence rate of bladder
cancer (24.1/100,000) [1]. The National Cancer Institute
(NCI) estimated that in 2009, there would be approxi-
mately 70,980 new cases and 14,330 deaths from bladder
cancer in the USA [2].
Despite reduced exposure to established risk factors
such as smoking, aromatic arylamines (occupation), and
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the USA remains high [3]. This is consistent with other
studies suggesting that these risk factors only partly explain
bladder cancer etiology [4, 5]. One etiologic study [6]
investigating regional variation in bladder cancer rates
across the USA also considered diet as a possible risk factor.
Several studies [7–14] have reported that dietary factors
such as fruit and vegetables may be protective against
bladder cancer. However, there is a lack of consistent evi-
dence between the intake of related micronutrient compo-
nents of fruits and vegetables and reduced risk of the disease
[5]. The Second Expert Report on nutrition and cancer by
the World Cancer Research Fund/American Institute of
Cancer Research states that the evidence was too limited to
conclude that any food or nutrient directly inﬂuences the
risk of bladder cancer [15]. Conversely, a recent systematic
review [16] as part of a WHO consultancy report found that
nutrient components of speciﬁc fruits and vegetables have a
possible inverse association with bladder cancer. It is these
dietary micronutrients or their metabolites that actually
come into direct contact with the bladder epithelium and
thus in theory could be protective [10].
VitaminA is obtainedfrom the diet as preformed vitamin
A from animal products and as carotenoids including both
provitamin A and non-provitamin A carotenoids from plant
foods [15].AninverseassociationbetweenvitaminAintake
and bladder cancer has been reported in some studies [17,
18], but not others [3, 19–21]. Inconsistencies may be due to
many earlier studies not distinguishing between these die-
tary sources [10]. Some recent studies suggest that it is the
carotenoids [8, 22–24]( a-carotene [8], b-carotene [8, 25],
b-cryptoxanthin [21], lycopene [8], lutein/zeaxanthin [8],
and not retinol [10,23,26]that inﬂuences the risk of bladder
cancer. Although, other studies have reported the opposite
effects, with some ﬁnding that retinol may actually be pro-
tective [18, 27–29] and others that the carotenoids have no
effect [3, 10, 19, 30, 31].
The relationship between bladder cancer and vitamin C
and E also appears to be unclear with some studies
reporting potential inverse associations (vitamin C: [29, 32,
33]; vitamin E: [20, 27]) and others no associations at all
(vitamin C: [3, 19, 21, 23, 25]; vitamin E: [3, 19, 21, 23,
25, 31]).
Deﬁciencies in folic acid, vitamins B3 (niacin), B6, B12,
have been reported to mimic radiation damage to DNA and
possibly lead to the initiation of cancer [34]. However,
there is only limited literature available on the association
between water-soluble B-group vitamins and risk of blad-
der cancer, and the ﬁndings have been inconsistent [20, 21,
23, 25, 28, 35].
Cohen [36] reviewed the effect of diet on bladder cancer
risk. He concluded that the potential for certain dietary
minerals to inﬂuence urine composition and hence bladder
carcinogenesis observed in animal studies needed further
evaluation before extrapolation could be made to human
populations. To date, few epidemiological studies have
investigated the effect of dietary minerals such as sodium
[20, 23], potassium [20], calcium [20, 23, 26], magnesium
[20], and iron [20, 26] on the risk of developing bladder
cancer.
Micronutrient deﬁciencies could provide a possible
explanation for why an estimated 25% of the US popula-
tion who consume the least fruit and vegetables have
double the cancer rate [34]. The aim of our study was to
investigate the association between major dietary minerals
and vitamins and the risk of bladder cancer in a US pop-
ulation from a region with a high incidence rate [37].
Methods
Study population
A population-based case–control study was conducted in
New Hampshire, USA. Details of the study have been
reported previously [38, 39]. Brieﬂy, bladder cancer cases
were identiﬁed from the New Hampshire State Department
of Health and Human Services Cancer Registry as histo-
logically conﬁrmed, primary bladder cancer diagnosed
between 1 July 1998 and 31 December 2001. To be eligible
for inclusion in the study, all cases had to be New
Hampshire residents aged between 25 and 74, have a listed
phone number and speak English. Physician consent was
obtained before contacting potential participants. Of the
472 potentially eligible cases we contacted, a total of 398
(84%) were interviewed for the study. For efﬁciency,
controls were shared with another study on non-melanoma
cancer covering a reference period from 1 July 1997 to 30
March 2000 [40]. Controls less than 65 years of age were
selected from lists obtained from the New Hampshire
Department of Transportation. Controls 65 years of age
and older were chosen from data ﬁles provided by the
Centers for Medicare & Medicaid Services (CMS) of New
Hampshire. Controls were randomly assigned a compara-
ble reference date to case group dates of diagnoses [41]. A
total of 526 controls (76%) were interviewed from a
potential 694 conﬁrmed eligible participants.
Data collection
Extensive in-person interviews were conducted with con-
sentingparticipants,usuallyinthehomesoftheparticipants.
Data were collected on participants’ socio-demographic
information such as education level, residence, occupation
(history),medical history,lifestyle factors (includingtobacco
smoking), household water supply, and family history of
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interviews were tape recorded with subjects’ consent (less
than 5% refused to have the interview taped) to ensure
consistent quality of the interview and clariﬁcation of
details. Cases were also asked if they held a driver’s license
or a Medicare enrollment card for comparability with
controls [42].
Dietary data
Interviews which included dietary assessment took place
between 2000 and 2003 for both cases and controls (for
95% of subjects). As data were unavailable for 150 cases
and 455 controls; a total of 322 cases and 239 controls were
included in the dietary analyses of this study. Subjects from
whom dietary data were collected were comparable to
those who did not provide dietary data with respect to age,
sex, and smoking history (data not shown).
Dietary information was collected from a 121-item semi-
quantitative food frequency questionnaire (FFQ) that was
developedbyWillettetal.fortheNurses’HealthStudy[43].
Participants were asked about their usual dietary intake for
the previous 12-month period. Foods items were assigned to
seven broad categories. These included dairy, fruit, vegeta-
bles, eggs and meat, breads, beverages, and baked goods.
There was a list of nine common mineral and vitamin sup-
plements to choose from which included the following:
multiple vitamins (participants were asked to report the
individual vitamins within this category), vitamins A, C, B6
and E, selenium, iron, zinc, and calcium. Additional ques-
tions covered folic acid, vitamin D, vitamin B complex, cod
liveroil,omega3fattyacids,iodine,copper,Brewer’syeast,
b-carotene, magnesium, and an open ended option, ‘‘other.’’
Participants were provided with options for duration of
supplement intake ranging from ‘‘0’’ to 10? years.
Frequency options ranged from never to six or more
times a day. Nutrient intake was calculated by multiplying
frequency of each food item on the FFQ by the nutrient
content for the speciﬁc portion size [44]. Food composition
data were based primarily on data from the United States
Department of Agriculture (USDA) [45].
We investigated vitamins that had a biologically plau-
sible association with bladder cancer and ‘‘macro-miner-
als’’, which are required in quantities greater than 100 mg
per day e.g., sodium, potassium, calcium, phosphorus, and
magnesium [20]. An exception was iron, which was
included due to its physiological function and potential to
inﬂuence the risk of bladder cancer [34].
Statistical analysis
We investigated the association between total mineral and
vitamin intake, which included micronutrients from both
dietary and supplemental sources and bladder cancer risk.
The intake of carotenoids, folate, and vitamin B12 were
measured in micrograms (lg) per day. All other vitamins
including, B1 (thiamin), B2 (riboﬂavin), B3 (niacin),
vitamin C and vitamin E, and minerals (sodium, potassium,
calcium, phosphorus, magnesium, and iron) were calcu-
lated in milligrams (mg) per day except for vitamin D
intake, which was calculated in international units (IU).
The data were analyzed in quartiles based on the control
group distributions. ORs and corresponding 95% CIs were
calculated using logistic regression analysis. Adjustment
was made for a number of possible confounding variables
including sex, age, cigarette smoking status (current/non-
current smoker), pack years of cigarette smoking (catego-
ries: 0\10, 10\20, 20\30, 30\40, 40\50, C50;
calculated by dividing the number of cigarettes smoked per
day by 20 and multiplying by the number of years smoked)
and total energy intake (quartiles for kcal/day). Additional
adjustment for other potential confounders, total fat intake
(fat-soluble vitamins), alcohol and coffee consumption
(water-soluble vitamins) did not alter the associations
between micronutrients and bladder cancer. Minerals and
vitamins were dichotomized according to median intakes
by controls. Odds ratios and 95% CIs were calculated to
investigate potential differences between invasive and non-
invasive bladder cancer. We also performed additional
analyses to assess the effects of minerals and vitamins from
both dietary and supplemental sources separately. Intake of
nutrients from dietary sources were analyzed in quartiles
using the same statistical model for total intake of minerals
and vitamins. We estimated the intake of minerals and
vitamins from supplements by subtracting dietary intake
from total nutrient intake. Due to the relatively small
contribution to mineral and vitamin intake by supplements
in this study population, these nutrients were dichotomized
according to average intake of controls. Likelihood ratio
tests were conducted to test for trend by assigning an
integer to each quartile of the nutrient e.g., 1–4 then ﬁt the
term as a continuous variable in the model. The joint
effects of speciﬁc nutrients and smoking status/history and
age were also investigated. Nutrients and age were
dichotomized into high and low categories based on med-
ian values of the controls. Smoking status was dichoto-
mized into never/ever smoker, cigarettes per day into high
and low categories (\20/C20 cigarettes per day) and
duration of smoking (\27 years/C27 years). We used the
likelihood ratio test to evaluate interaction, i.e., comparing
the log likelihood of regression models with and without
the interaction term included. The false-positive report
probability (FPRP) was employed to assess the probability
of no true association between nutrients and the risk of
bladder cancer given a statistically signiﬁcant ﬁnding [46].
This test takes into account three factors that determine the
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ally be a false-positive ﬁnding. These are (1) prior proba-
bility of an association; (2) the alpha-level, and (3)
statistical power to detect an odds ratio for the alternative
hypothesis at a given alpha-level or p value. We used
previously reported arbitrary values for these factors: 0.05
(alpha-level), 0.25 (prior probability), and 0.5 (false-posi-
tive report probability) [46, 47].
All reported p values were two-sided and values less
than or equal to 0.05 were considered to be statistically
signiﬁcant. The statistical software package Stata/SE 10.0
(Stata Corporation, College Station, TX, USA) was used
for all statistical analyses.
Results
Study characteristics
Table 1 presents the frequency distributions of selected
study characteristics for the 322 cases and 239 controls for
whom dietary data were available for analyses in this
study. Bladder cancer cases consisted of approximately
three times more men (74%) than women. A majority of
both cases and controls were in the older age group
(60 years and over). There was a higher prevalence of
current smokers and greater number of both cigarettes
smoked per day and years smoked among cases compared
with the controls. We detected no statistically signiﬁcant
differences between cases and controls for calorie, total fat,
alcohol, or coffee intake.
Total intake of minerals and vitamins and the risk
of bladder cancer
Table 2 shows the ORs and 95% CIs for bladder cancer
and total intake (including dietary and supplemental sour-
ces) of fat-soluble and water-soluble vitamins. We
observed a borderline statistically signiﬁcant inverse
association between total intake of vitamin E and bladder
cancer (highest vs. lowest quartile, OR: 0.66; 95% CI:
0.36–1.20; p trend = 0.09). No statistically signiﬁcant ORs
were observed when comparing the highest quartile of
intake with the lowest quartile for carotenoids as a group or
for any of the individual carotenoids, a-carotene, b-caro-
tene, b-cryptoxanthin, lycopene, or lutein/zeaxanthin.
Although the point estimate for vitamin D was well below
one, this also did not reach statistical signiﬁcance (OR:
0.58; 95% CI: 0.31–1.06; p trend = 0.22).
Among the water-soluble vitamins, the OR for niacin
and bladder cancer was of borderline statistical signiﬁcance
(highest vs. lowest quartile OR: 0.56; 95% CI: 0.31–1.02).
No other associations were observed between bladder
cancer and any other B-group or water-soluble vitamins,
which included thiamin, riboﬂavin, B6, B12, and folate or
vitamin C. Similarly, no associations were observed
between bladder cancer and total intake for any of the
minerals reported in Table 3, including sodium, potassium,
magnesium, calcium, phosphorus, and iron. Nor were there
any detectable differences in the effects of any of the
minerals and vitamins between invasive and non-invasive
bladder cancer.
Analyses were repeated for all minerals and vitamins
using measures taken from both dietary sources (excluding
supplements) and supplements alone (data not shown). The
only nutrient of interest to emerge from dietary sources
alone when comparing highest quartiles of intake with
lowest quartiles of intake, although not statistically sig-
niﬁcant was phosphorus (OR: 0.49; 95% CI: 0.21–1.17;
p trend = 0.13). No other associations or trends could be
observed for any of the other dietary or supplemental
sources of minerals and vitamins.
We continued analyses for minerals and vitamins where
an association had been indicated either from borderline
Table 1 Distribution of bladder cancer cases and controls by
demographic characteristics and bladder cancer risk factors
Cases
number (%)
Controls
number (%)
Total 322 239
Sex*
Men 237 (74) 138 (58)
Women 85 (26) 101 (42)
Age (years) [mean (SD)] 62 (9.2) 60.7 (10.6)
Smoking status*
Never smokers 56 (17.4) 95 (39.7)
Ex-smokers 162 (50.3) 103 (43.1)
Current smokers 104 (32.3) 41 (17.2)
Years smoking [mean (SD)]* 32.2 (14) 27.4 (15)
Cigarettes/day [mean (SD)]* 26.7 (14.8) 22.3 (15.6)
Total calories kcal/day
[mean (SD)]
1962.56 (790.72) 1887.74 (706.64)
Total fat g/day [mean (SD)] 71.74 (32.96) 69.77 (31.76)
Total alcohol g/day
[mean (SD)]
7.91 (15.84) 8.29 (14.45)
Total coffee g/day
[mean (SD)]
227.41 (210.13) 216.57 (192.88)
Tumor stage at diagnosis
Carcinoma in situ (%) 16 (5)
Non-invasive/low grade (%) 190 (59)
Non-invasive/high grade (%) 23 (7)
Invasive (%) 93 (29)
SD standard deviation
* Statistically signiﬁcant differences between cases and controls;
p\0.05
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123Table 2 Calculated odds ratios (95%) for total intake of vitamins and bladder cancer
Daily intake Q1 Q2 Q3 Q4 p Trend
Alpha-carotene (lg) 3.4–404 404.1–647.13 647.14–1104.70 C1104.71 0.26
Cases/controls 76/59 89/60 77/61 77/59
ORs (95% CI) 1.00 1.33 (0.77–2.30) 1.19 (0.68–2.11) 1.48 (0.83–2.64)
Beta-carotene (lg) 292.29–2294.21 2294.22–3773.80 3773.81–5517.20 C5517.21 0.90
Cases/controls 94/59 78/61 65/60 79/59
ORs (95% CI) 1.00 0.87 (0.50–1.50) 0.80 (0.46–1.39) 0.99 (0.56–1.72)
Beta-cryptoxanthin (lg) 0–52.60 52.61–125.77 125.78–215.71 C215.72 0.65
Cases/controls 109/59 76/61 59/58 78/61
ORs (95% CI) 1.00 0.69 (0.40–1.20) 0.66 (0.37–1.16) 0.87 (0.50–1.53)
Lycopene (lg) 0–3092.68 3092.69–4827 4828–7746.43 C7746.44 0.74
Cases/controls 89/59 73/60 72/60 88/60
ORs (95% CI) 1.00 0.96 (0.55–1.66) 0.70 (0.39–1.24) 0.98 (0.55–1.73)
Lutein (lg) 0.93–1261.48 1261.49–1942.44 1942.45–3134.85 C3134.86 0.66
Cases/controls 116/58 61/61 74/60 70/59
ORs (95% CI) 1.00 0.52 (0.30–0.90) 0.76 (0.45–1.31) 0.80 (0.46–1.40)
Total carotenoids (lg) 398.26–8879.22 8879.23–12900.60 12900.61–17932.72 C17932.73 0.47
Cases/controls 107/59 73/60 52/60 87/60
ORs (95% CI) 1.00 0.70 (0.41–1.21) 0.49 (0.27–0.86) 0.90 (0.51–1.59)
Vitamin D (IU) 15.53–171.74 171.75–388.90 388.91–641.12 C641.13 0.22
Cases/controls 89/59 72/60 100/60 61/60
ORs (95% CI) 1.00 0.78 (0.44–1.38) 1.03 (0.60–1.76) 0.58 (0.31–1.06)
Vitamin E (mg) 1.13–7.26 7.27–20.94 20.95–193.35 C193.36 0.09
Cases/controls 77/57 95/58 81/57 54/57
ORs (95% CI) 1.00 1.19 (0.68–2.08) 0.88 (0.49–1.56) 0.66 (0.36–1.20)
Thiamin (mg) 0.21–1.32 1.33–2.11 2.12–3.34 C3.35 0.50
Cases/controls 91/58 63/59 99/63 67/58
ORs (95% CI) 1.00 0.53 (0.29–0.96) 0.97 (0.56–1.68) 0.63 (0.35–1.14)
Riboﬂavin (mg) 0.25–1.63 1.64–2.75 2.76–4.04 C4.05 0.61
Cases/controls 85/60 74/59 91/61 71/59
ORs (95% CI) 1.00 0.73 (0.41–1.29) 1.02 (0.58–1.77) 0.75 (0.42–1.34)
Niacin (B3) (mg) 5.77–21.91 21.92–33.07 33.08–46.50 C46.51 0.23
Cases/controls 90/58 68/60 93/60 67/60
ORs (95% CI) 1.00 0.59 (0.33–1.06) 0.94 (0.54–1.64) 0.56 (0.31–1.02)
Vitamin B6 (mg) 0.32–1.94 1.95–3.28 3.29–4.88 C4.89 0.41
Cases/controls 93/59 75/59 77/61 75/59
ORs (95% CI) 1.00 0.67 (0.38–1.18) 0.82 (0.47–1.44) 0.72 (0.41–1.27)
Vitamin B12 (lg) 0.75–5.51 5.52–10.82 10.83–18.0 C18.1 0.75
Cases/controls 79/60 89/60 65/60 87/59
ORs (95% CI) 1.00 1.30 (0.75–2.26) 0.84 (0.47–1.51) 1.05 (0.60–1.84)
Folate (lg) 48.41–339.03 339.04–579.10 579.11–819.50 C819.51 0.43
Cases/controls 82/59 82/61 85/59 71/60
ORs (95% CI) 1.00 0.83 (0.47–1.46) 0.91 (0.53–1.56) 0.74 (0.40–1.35)
Vitamin C (mg) 14.61–113.03 113.04–190.25 190.26–366.10 C366.11 0.42
Cases/controls 98/58 78/60 80/61 62/59
ORs (95% CI) 1.00 0.83 (0.48–1.43) 0.84 (0.48–1.45) 0.78 (0.45–1.38)
OR odds ratios, CI conﬁdence intervals, adjusted for age, sex, smoking status: current versus non-current smoker, pack years smoked (categories:
0–10, 10–20, 20–30, 30–40, 40–50, 50?), and total energy intake (quartiles kcal/day)
Cancer Causes Control (2010) 21:609–619 613
123associations and biological plausibility or from previous
studies. Minerals and vitamins that met the criteria were
investigated for interactions with smoking characteristics
and age, which were both adjusted for each other. The joint
effects of nutrient intake and established risk factors e.g.,
smoking status (ever/never), cigarettes per day (\20/C20/
day), duration of smoking (\27 years/C27 years), and age
(\63 years/C63 years) are presented in Table 4. The OR
for heavy cigarette smokers (C20 cigarettes per day) in the
highest group for total intake of vitamin E, was 0.58 (95%:
0.34–0.99; p interaction 0.03). Inverse associations of
borderline statistical signiﬁcance were also observed
among heavy smokers for the highest intake of total
carotenoids (OR: 0.62; 95% CI: 0.36–1.09; p interaction
0.08) and niacin (OR: 0.66; 95% CI: 0.39–1.14; p inter-
action 0.08). Interaction between thiamin intake and the
number of cigarettes smoked per day was also of borderline
statistical signiﬁcance. Possible reductions in risk of
bladder cancer for older participants were also associated
with higher intakes of total carotenoids (OR: 0.59; 95% CI:
0.35–0.99), vitamin D, thiamin, and niacin (p interaction:
0.04, 0.02, and 0.03, respectively). No other statistically
signiﬁcant associations were observed, although there were
reduced odds of bladder cancer among the older age group
for the highest intake of vitamin E (OR: 0.61; 95%
CI: 0.37–1.02) and interactions between vitamin C and
ever-smoking (p = 0.08) and vitamin C and age
(p = 0.08) were borderline (data not shown).
The statistically signiﬁcant inverse associations
observed between total intake of carotenoids, vitamin D,
thiamin, and niacin and the risk of bladder cancer for older
individuals remained robust following the FPRP test. Each
inverse association had less than a 50% likelihood of being
false positive for an odds ratio of 1.5 and based on a prior
probability of 25%,
Discussion
Main ﬁndings
We investigated an extensive range of micronutrients in
relation to the risk of bladder cancer. Possible inverse
associations of borderline statistical signiﬁcance were
observed between bladder cancer and total intake of vita-
min E and dietary phosphorus. We found some evidence
that total intake of vitamin E, total carotenoids, niacin and
possibly thiamin might be modiﬁed by cigarette smoking in
that inverse associations were observed largely among
heaviest smokers. Higher intakes of carotenoids, vitamin
D, thiamin, niacin, and vitamin E were also associated with
reduced odds of bladder cancer in the older age group. No
Table 3 Calculated odds ratios (95%) for total intake of minerals and bladder cancer
Daily intake Q1 Q2 Q3 Q4 p Trend
Sodium (mg) 344.61–1484.83 1484.84–1898.64 1898.65–2372.65 C2372.66 0.32
Cases/controls 78/58 64/60 59/60 119/60
ORs (95% CI) 1.00 1.17 (0.61–2.23) 1.00 (0.48–2.12) 1.66 (0.70–3.92)
Potassium (mg) 535.63–2382.5 2382.6–2874.24 2874.25–3781.33 C3781.34 0.58
Cases/controls 101/59 45/60 95/61 80/59
ORs (95% CI) 1.00 0.50 (0.27–0.91) 1.03 (0.53–2.0) 0.65 (0.29–1.45)
Calcium (mg) 86.63–600.36 600.37–918.23 918.24–1346.4 C1346.5 0.27
Cases/controls 99/59 73/60 90/59 60/60
ORs (95% CI) 1.00 0.60 (0.35–1.05) 0.88 (0.50–1.53) 0.60 (0.32–1.13)
Magnesium (mg) 58.76–259.03 259.04–328.08 328.09–418.58 C418.59 0.20
Cases/controls 95/59 62/61 83/60 80/59
ORs (95% CI) 1.00 0.65 (0.36–1.15) 0.79 (0.43–1.44) 0.56 (0.27–1.16)
Phosphorus (mg) 177.85–965.2 965.3–1195.67 1195.68–1556.5 C1556.6 0.46
Cases/controls 93/60 65/59 81/61 83/59
ORs (95% CI) 1.00 1.02 (0.55–1.92) 0.93 (0.44–1.98) 0.70 (0.28–1.75)
Iron (mg) 2.12–11.25 11.26–15.56 15.57–23.20 C23.21 0.93
Cases/controls 82/59 75/60 77/60 86/60
ORs (95% CI) 1.00 1.04 (0.57–1.90) 0.92 (0.49–1.73) 1.06 (0.57–1.96)
OR odds ratios, CI conﬁdence intervals, adjusted for age, sex, smoking status: current versus non-current smoker, pack years smoked (categories:
0–10, 10–20, 20–30, 30–40, 40–50, 50?), and total energy intake (quartiles kcal/day)
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123other associations were apparent between bladder cancer
and any other mineral or vitamin.
Previous ﬁndings
The potentially protective effect of vitamin E that we
observed against developing bladder cancer was consistent
with ﬁndings from two other US studies [20, 27]. However,
we detected no association between risk of bladder cancer
overall and the intake of carotenoids either as individual
carotenoids (a-carotene, b-carotene, b-cryptoxanthin,
lycopene, and lutein/zeaxanthin) or collectively as total
carotenoid intake. Our ﬁndings were in agreement with an
intervention study [31], a meta-analysis [10], two pro-
spective studies [3, 20], and one case–control study [30].
Conversely, four case–control studies [8, 22, 23, 48]
observed inverse associations with carotenoid intake and
two other prospective studies [21, 25] found speciﬁc
carotenoids, dietary beta-carotene [25] and beta-crypto-
xanthin [21] to be possibly protective.
Like previous studies, we investigated the most common
carotenoids from an estimated 40 carotenoids present in the
human diet [22]. Each carotenoid is considered to have a
speciﬁc biological function [22]. While some carotenoids
have potential to form vitamin A (provitamin A carote-
noids include, a-carotene, b-carotene, and b-cryptoxanthin)
others do not have this capability (non-provitamin A
carotenoids are lycopene, lutein, and zeaxanthin) [15].
Contrary to an earlier study [22], we did not ﬁnd either of
these two categories of carotenoids to be associated with
the risk of bladder cancer (data not shown). Any chemo-
preventive effect may be difﬁcult to detect for individual
carotenoids either due to the relatively small sample size,
small size of the effect or because carotenoids possibly
only work in synergy with each other or other dietary
factors [49].
Where a relatively large prospective study of US men
[20] and a case–control study [23] both reported no asso-
ciation between vitamin D and bladder cancer, we observed
reduced odds of bladder cancer with higher intake of
vitamin D; although this was not statistically signiﬁcant.
The anti-proliferative effect of vitamin D has been shown
in various in vitro and in vivo investigations [50]. How-
ever, as vitamin D is available from both dietary sources
and UV-B radiation [50], it is difﬁcult to estimate the full
effect of vitamin D without taking into account sunlight
exposure.
Although B-group vitamins are thought to possibly offer
protection via their role in genomic stability, DNA repair,
and regulation of cell division [15], we did not detect any
associations between any B-group vitamin and bladder
cancer overall. This was consistent with three previous
prospective studies [20, 21, 25] and one retrospective study
[23] but disagreed with two other recent case–control
studies [28, 35]. We also failed to detect any association
between bladder cancer and another water-soluble vitamin
with antioxidant potential, vitamin C. Once again, there
were conﬂicting reports relating to the effect of vitamin C
on bladder cancer risk among the various studies [3, 8, 19–
21, 23, 29, 32, 33]. When reviewing the existing literature
on vitamin C and many of the other vitamins, any evidence
for an association generally appeared to be weaker in
prospective studies compared with case–control studies [7].
Lack of association between some micronutrients and
bladder cancer might also be due to collinearity among
nutrients as a result of shared food sources [51]. For
instance, many fruits and vegetables rich in carotenoids are
also good sources of vitamin C, potassium, and folate.
To our knowledge, phosphorus has been investigated in
relation to bladder cancer in only one other epidemiolog-
ical study [20] that reported no association following
multivariate analyses. Although we observed an approxi-
mate 50% reduction in the odds of bladder cancer associ-
ated with higher dietary intake of phosphorus, it was not
statistically signiﬁcant. Given this ubiquitous micronutrient
is an important physiological component of DNA, RNA,
ATP, and cell membranes, it may be worthy of further
consideration [52].
In our study, a higher intake of vitamin E related to a
reduced risk of bladder cancer among heaviest smokers, a
ﬁnding consistent with those reported in another American
case–control study [27]. The reduced odds of bladder
cancer we observed for the highest quartile of total
carotenoids among the heaviest smokers also agrees with
results presented in another case–control study conducted
in the USA [8]. Two additional American case–control
studies [22, 48] also reported increased risk of bladder
cancer among smokers with the lower intakes of total [22]
and speciﬁc carotenoids, lutein, and zeaxanthin [48].
Castelao et al. [8] suggested that carotenoids provide pro-
tection against bladder cancer for smokers by detoxifying
arylamines. Borderline statistically signiﬁcant interactions
between the number of cigarettes smoked per day and
intakes of thiamin and niacin may warrant further
investigation.
Our ﬁndings indicate that higher intakes of vitamin D,
thiamin, niacin, carotenoids, and possibly vitamin E may
be beneﬁcial to participants in the older age group. Older
individuals may have limited access to regular sunshine
(e.g., living in institutions) and therefore have to rely
strongly on dietary sources of vitamin D and supplemen-
tation. Bladder cancer is a disease that typically affects
older people [53], and bioavailability of B-group vitamins
may be compromised in this demographic by certain drugs
(e.g., acid lowering agents) [54]. Additionally, vitamin E,
like carotenoids acts as an antioxidant and, as suggested by
616 Cancer Causes Control (2010) 21:609–619
123our results, could be more beneﬁcial under conditions
of the greatest oxidative stress such as smoking and aging
[27].
Strengths and limitations
There were limitations associated with our study. Like
most case–control studies, potential for recall bias is a
consideration in dietary estimation. However, as dietary
factors are not commonly associated with bladder cancer
etiology recall of dietary intake is likely to be non-differ-
ential between cases and controls. Other potential limita-
tions relating to measurement of dietary exposures include
only one dietary collection period and the possibility of
preclinical disease altering dietary intake. Although there
was only one collection period, dietary data were collected
using a detailed and validated FFQ [43]. As for dietary
change, a majority of the cases in our study were diagnosed
with superﬁcial bladder cancer, and it is considered unli-
kely that preclinical disease would alter dietary behavior
[28]. Although we cannot totally exclude the possibility of
recall bias, dietary intake for major dietary components;
calories, total fat, alcohol, and coffee were comparable
between cases and controls suggesting that it should be
minimal.
Finally, controls were drawn from two sources—
Department of Transportation (for those under 65 years)
and Medicare (for those 65 years and older). These are
considered nearly complete sources of records in our
population. Among cases, over 95% report having a dri-
ver’s license (for those under 65 years) as do over 95% (of
those 65 years and older) report being enrolled in Medicare
(data not shown). We examined the characteristics of
controls younger than 65 years and over 65 years and
found them to be comparable with respect to sex, smoking,
and medical access variables (i.e., visit to a doctor in the
past 2 years); however, older subjects had less than a col-
lege education (40% of those under 65 years and 50% of
those 65 years and older). However, level of education is
not a strong risk factor for bladder cancer (including in our
own data) and thus was not considered a potential con-
founder in our analysis.
While multiple comparisons were made in this study, we
attempted to address this issue by utilizing the FPRP [46].
Statistically signiﬁcant associations between higher intakes
of carotenoids, vitamin D, thiamin, and niacin and risk of
bladder cancer among the older individuals remained
robust following this test. Although it is worth noting that
statistical power was low and determining appropriate prior
probabilities is difﬁcult [55]. Biologically plausible
mechanisms of action and similar results reported from
other studies provide additional support for some of our
ﬁndings [8, 20, 27].
Conclusion
In conclusion, the effects of vitamin E, carotenoids, vita-
min D, thiamin, and niacin in relation to the risk of
developing bladder cancer may warrant further investiga-
tion. Future studies should focus on optimal doses and
combinations of these micronutrients particularly for high
risk groups such as heavy smokers and older individuals.
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